Guía detallada disponible en inglés. MFMD ofrece orientación y coordinación del centro en español.
Potentially, yes — but the clinic must satisfy both medical-evaluation requirements and controlled-substance rules. Florida allows telehealth evaluations when the information is sufficient to diagnose and treat. Testosterone is Schedule III, so current federal DEA telemedicine rules also apply. Do not assume a questionnaire-only encounter is sufficient for initial testosterone prescribing.
Abrir la explicación completa3 secciones y fuentes primarias
What is the evaluation meant to establish before testosterone is prescribed?
The evaluation determines whether treatment is appropriate for that individual, identifies safety factors that may require modification or further evaluation, and establishes the patient-specific plan — not simply a rubber stamp.
What is the caution on asynchronous evaluation for TRT?
Florida recognizes asynchronous telehealth, but DEA’s current temporary controlled-substance telemedicine flexibility is framed around specified encounter requirements (including audio-video for controlled medications under the temporary extension). Both the clinical-evaluation workflow and the federal controlled-substance pathway must be satisfied. (Reviewed August 2026; verify current DEA status.)
Owner takeaway
For TRT, “Florida allows asynchronous telehealth” is not the end of the analysis, because testosterone is controlled. Build the workflow around both requirements.